EAM Global Investors’s BioLife Solutions BLFS Stock Holding History

EAM Global Investors’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-67,097	Closed	-$2.68M	–	146
2020 Q4	$2.68M	Sell	67,097 -9,541	-12%	-$325K	0.73%	57
2020 Q3	$2.22M	Buy	+76,638	New	+$1.66M	0.81%	49
2018 Q4	–	Sell	-55,443	Closed	-$970K	–	129
2018 Q3	$970K	Sell	55,443 -57,939	-51%	-$1.15M	0.39%	135
2018 Q2	$1.29M	Buy	+113,382	New	+$1.03M	0.63%	76

Other funds holding BLFS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

EAM Global Investors's BLFS Position: Q1 2021 in Review

EAM Global Investors sold out of BioLife Solutions (BLFS) in Q1 2021, closing a stake of 67,097 shares — an estimated $2.68M sold.

EAM Global Investors first reported a position in BLFS in Q2 2018 and held it in 4 quarters. The position peaked at $2.68M in Q4 2020. 132 funds tracked by Wall St. Rank hold BLFS as of Q1 2021.

EAM Global Investors reported no remaining BioLife Solutions position as of Q1 2021 after selling out during the quarter.
EAM Global Investors sold 67,097 BioLife Solutions shares in Q1 2021, an estimated $2.68M.
EAM Global Investors first reported a position in BioLife Solutions in Q2 2018 and held it in 4 quarters.
EAM Global Investors's BioLife Solutions position peaked at $2.68M in Q4 2020.
132 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2021.

Based on EAM Global Investors's 13F filing for Q1 2021, filed 11 May 2021.